Marcus O Butler (Marcus Butler)

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 49

Top Topics

Basal Cell Carcinoma

Top Venues

Nature medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Erica C Koch Hein, Maysa Vilbert, Ian Hirsch, Maurício Fernando Silva Almeida Ribeiro, Thiago P Muniz, Cynthia Fournier, Khaled Abdulalem, Erick Figueiredo Saldanha, Erika Martinez, Anna Spreafico, David H Hogg, Marcus O Butler, Samuel D Saibil
Immune Checkpoint Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience from a Canadian Comprehensive Cancer Centre. Cancers 15 (17) (2023)
David S Hong, Brian Andrew Van Tine, Swethajit Biswas, Cheryl McAlpine, Melissa L Johnson, Anthony J Olszanski, Jeffrey M Clarke, Dejka Araujo, George R Blumenschein, Partow Kebriaei, Quan Lin, Alex J Tipping, Joseph P Sanderson, Ruoxi Wang, Trupti Trivedi, Thejo Annareddy, Jane Bai, Stavros Rafail, Amy Sun, Lilliam Fernandes, Jean-Marc Navenot, Frederic D Bushman, John K Everett, Derin Karadeniz, Robyn Broad, Martin Isabelle, Revashnee Naidoo, Natalie Bath, Gareth Betts, Zohar Wolchinsky, Dzmitry G Batrakou, Erin Van Winkle, Erica Elefant, Armin Ghobadi, Amanda Cashen, Anne Grand'Maison, Philip McCarthy, Paula M Fracasso, Elliot Norry, Dennis Williams, Mihaela Druta, David A Liebner, Kunle Odunsi, Marcus O Butler
Autologous T cell therapy for MAGE-A4 + solid cancers in HLA-A*02 + patients: a phase 1 trial. Nature medicine 29 (1) (2023)
Saeed Moradian, Roma Maguire, Geoffrey Liu, Monika K Krzyzanowska, Marcus O Butler, Chantal Cheung, Marisa Signorile, Nancy Gregorio, Shiva Ghasemi, Doris M Howell
Promoting Self-management and Patient Activation Through eHealth: Protocol for a Systematic Literature Review and Meta-analysis. JMIR research protocols 12 (2023)
Abdulazeez Salawu, Ben X Wang, Ming Han, Caryn Geady, Alya Heirali, Hal K Berman, Thomas D Pfister, Alberto Hernando-Calvo, Esmail Mutahar Al-Ezzi, Lee-Anne Stayner, Abha A Gupta, Olubukola Ayodele, Bernard Lam, Aaron Richard Hansen, Anna Spreafico, Philippe L Bedard, Marcus O Butler, Lisa Avery, Bryan Coburn, Benjamin Haibe-Kains, Lillian L Siu, Albiruni Abdul Razak
Safety, immunologic and clinical activity of Durvalumab in combination with Olaparib or Cediranib in advanced leiomyosarcoma: Results of the DAPPER clinical trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Raffit Hassan, Marcus O Butler, Roisin E O'Cearbhaill, David Y Oh, Melissa Lynne Johnson, Kevin Zikaras, Munisha Smalley, Michael Ross, Janos L Tanyi, Azam Ghafoor, Nirali N Shah, Babak Saboury, Liang Cao, Alfonso Quintás-Cardama, David S Hong
Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results. Nature medicine (2023)
Morven E Cunningham, Rohit Gupta, Marcus O Butler
Checkpoint inhibitor hepatotoxicity: pathogenesis and management. Hepatology (Baltimore, Md.) (2023)
David S Hong, Brian Andrew Van Tine, Swethajit Biswas, Cheryl McAlpine, Melissa L Johnson, Anthony J Olszanski, Jeffrey M Clarke, Dejka Araujo, George R Blumenschein, Partow Kebriaei, Quan Lin, Alex J Tipping, Joseph P Sanderson, Ruoxi Wang, Trupti Trivedi, Thejo Annareddy, Jane Bai, Stavros Rafail, Amy Sun, Lilliam Fernandes, Jean-Marc Navenot, Frederic D Bushman, John K Everett, Derin Karadeniz, Robyn Broad, Martin Isabelle, Revashnee Naidoo, Natalie Bath, Gareth Betts, Zohar Wolchinsky, Dzmitry G Batrakou, Erin Van Winkle, Erica Elefant, Armin Ghobadi, Amanda Cashen, Anne Grand'Maison, Philip McCarthy, Paula M Fracasso, Elliot Norry, Dennis Williams, Mihaela Druta, David A Liebner, Kunle Odunsi, Marcus O Butler
Autologous T cell therapy for MAGE-A4 + solid cancers in HLA-A*02 + patients: a phase 1 trial. Nature medicine 29 (1) (2023)
David S Hong, Brian Andrew Van Tine, Swethajit Biswas, Cheryl McAlpine, Melissa L Johnson, Anthony J Olszanski, Jeffrey M Clarke, Dejka Araujo, George R Blumenschein, Partow Kebriaei, Quan Lin, Alex J Tipping, Joseph P Sanderson, Ruoxi Wang, Trupti Trivedi, Thejo Annareddy, Jane Bai, Stavros Rafail, Amy Sun, Lilliam Fernandes, Jean-Marc Navenot, Frederic D Bushman, John K Everett, Derin Karadeniz, Robyn Broad, Martin Isabelle, Revashnee Naidoo, Natalie Bath, Gareth Betts, Zohar Wolchinsky, Dzmitry G Batrakou, Erin Van Winkle, Erica Elefant, Armin Ghobadi, Amanda Cashen, Anne Grand'Maison, Philip McCarthy, Paula M Fracasso, Elliot Norry, Dennis Williams, Mihaela Druta, David A Liebner, Kunle Odunsi, Marcus O Butler
Autologous T cell therapy for MAGE-A4 + solid cancers in HLA-A*02 + patients: a phase 1 trial. Nature medicine 29 (1) (2023)
Saeed Moradian, Roma Maguire, Geoffrey Liu, Monika K Krzyzanowska, Marcus O Butler, Chantal Cheung, Marisa Signorile, Nancy Gregorio, Shiva Ghasemi, Doris M Howell
Promoting Self-management and Patient Activation Through eHealth: Protocol for a Systematic Literature Review and Meta-analysis. JMIR research protocols 12 (2023)
Maysa Vilbert, Erica C Koch, April A N Rose, Rob C Laister, Diana Gray, Valentin Sotov, Susanne Penny, Anna Spreafico, Devanand M Pinto, Marcus O Butler, Samuel D Saibil
Analysis of the Circulating Metabolome of Patients with Cutaneous, Mucosal and Uveal Melanoma Reveals Distinct Metabolic Profiles with Implications for Response to Immunotherapy. Cancers 15 (14) (2023)
David S Hong, Brian Andrew Van Tine, Swethajit Biswas, Cheryl McAlpine, Melissa L Johnson, Anthony J Olszanski, Jeffrey M Clarke, Dejka Araujo, George R Blumenschein, Partow Kebriaei, Quan Lin, Alex J Tipping, Joseph P Sanderson, Ruoxi Wang, Trupti Trivedi, Thejo Annareddy, Jane Bai, Stavros Rafail, Amy Sun, Lilliam Fernandes, Jean-Marc Navenot, Frederic D Bushman, John K Everett, Derin Karadeniz, Robyn Broad, Martin Isabelle, Revashnee Naidoo, Natalie Bath, Gareth Betts, Zohar Wolchinsky, Dzmitry G Batrakou, Erin Van Winkle, Erica Elefant, Armin Ghobadi, Amanda Cashen, Anne Grand'Maison, Philip McCarthy, Paula M Fracasso, Elliot Norry, Dennis Williams, Mihaela Druta, David A Liebner, Kunle Odunsi, Marcus O Butler
Autologous T cell therapy for MAGE-A4 + solid cancers in HLA-A*02 + patients: a phase 1 trial. Nature medicine 29 (1) (2023)
Derek Wong, Ping Luo, Nadia Znassi, Diana Paola Arteaga Ceballos, Diana Gray, Arnavaz Danesh, Ming Han, Eric Y Zhao, Stephanie Pedersen, Stephenie D Prokopec, Yogi Sundaravadanam, Dax Torti, Kayla Marsh, Sareh Keshavarzi, Wei Xu, Hatem Krema, Anthony M Joshua, Marcus O Butler, Trevor J Pugh
Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma. Cancer research communications 3 (2) (2023)
Saeed Moradian, Roma Maguire, Geoffrey Liu, Monika K Krzyzanowska, Marcus O Butler, Chantal Cheung, Marisa Signorile, Nancy Gregorio, Shiva Ghasemi, Doris M Howell
Promoting Self-management and Patient Activation Through eHealth: Protocol for a Systematic Literature Review and Meta-analysis. JMIR research protocols 12 (2023)
Saeed Moradian, Roma Maguire, Geoffrey Liu, Monika K Krzyzanowska, Marcus O Butler, Chantal Cheung, Marisa Signorile, Nancy Gregorio, Shiva Ghasemi, Doris M Howell
Promoting Self-management and Patient Activation Through eHealth: Protocol for a Systematic Literature Review and Meta-analysis. JMIR research protocols 12 (2023)
Derek Wong, Ping Luo, Nadia Znassi, Diana Paola Arteaga Ceballos, Diana Gray, Arnavaz Danesh, Ming Han, Eric Y Zhao, Stephanie Pedersen, Stephenie D Prokopec, Yogi Sundaravadanam, Dax Torti, Kayla Marsh, Sareh Keshavarzi, Wei Xu, Hatem Krema, Anthony M Joshua, Marcus O Butler, Trevor J Pugh
Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma. Cancer research communications 3 (2) (2023)
David S Hong, Brian Andrew Van Tine, Swethajit Biswas, Cheryl McAlpine, Melissa L Johnson, Anthony J Olszanski, Jeffrey M Clarke, Dejka Araujo, George R Blumenschein, Partow Kebriaei, Quan Lin, Alex J Tipping, Joseph P Sanderson, Ruoxi Wang, Trupti Trivedi, Thejo Annareddy, Jane Bai, Stavros Rafail, Amy Sun, Lilliam Fernandes, Jean-Marc Navenot, Frederic D Bushman, John K Everett, Derin Karadeniz, Robyn Broad, Martin Isabelle, Revashnee Naidoo, Natalie Bath, Gareth Betts, Zohar Wolchinsky, Dzmitry G Batrakou, Erin Van Winkle, Erica Elefant, Armin Ghobadi, Amanda Cashen, Anne Grand'Maison, Philip McCarthy, Paula M Fracasso, Elliot Norry, Dennis Williams, Mihaela Druta, David A Liebner, Kunle Odunsi, Marcus O Butler
Autologous T cell therapy for MAGE-A4 + solid cancers in HLA-A*02 + patients: a phase 1 trial. Nature medicine 29 (1) (2023)
Saeed Moradian, Roma Maguire, Geoffrey Liu, Monika K Krzyzanowska, Marcus O Butler, Chantal Cheung, Marisa Signorile, Nancy Gregorio, Shiva Ghasemi, Doris M Howell
Promoting Self-management and Patient Activation Through eHealth: Protocol for a Systematic Literature Review and Meta-analysis. JMIR research protocols 12 (2023)
David S Hong, Brian Andrew Van Tine, Swethajit Biswas, Cheryl McAlpine, Melissa L Johnson, Anthony J Olszanski, Jeffrey M Clarke, Dejka Araujo, George R Blumenschein, Partow Kebriaei, Quan Lin, Alex J Tipping, Joseph P Sanderson, Ruoxi Wang, Trupti Trivedi, Thejo Annareddy, Jane Bai, Stavros Rafail, Amy Sun, Lilliam Fernandes, Jean-Marc Navenot, Frederic D Bushman, John K Everett, Derin Karadeniz, Robyn Broad, Martin Isabelle, Revashnee Naidoo, Natalie Bath, Gareth Betts, Zohar Wolchinsky, Dzmitry G Batrakou, Erin Van Winkle, Erica Elefant, Armin Ghobadi, Amanda Cashen, Anne Grand'Maison, Philip McCarthy, Paula M Fracasso, Elliot Norry, Dennis Williams, Mihaela Druta, David A Liebner, Kunle Odunsi, Marcus O Butler
Autologous T cell therapy for MAGE-A4 + solid cancers in HLA-A*02 + patients: a phase 1 trial. Nature medicine (2023)
James M G Larkin, Michele Del Vecchio, Mario Mandala, Helen J Gogas, Ana M Arance, Stephane Dalle, Charles Lance Cowey, Michael Schenker, Jean-Jacques Grob, Vanna Chiarion Sileni, Ivan Marquez-Rodas, Marcus O Butler, Anna Maria Di Giacomo, Mark Ross Middleton, Jose Lutzky, Luis de la Cruz Merino, Petr Arenberger, Victoria Atkinson, Andrew G Hill, Leslie A Fecher, Michael Millward, Paul D Nathan, Nikhil I Khushalani, Paola Queirolo, Corey Ritchings, Maurice Lobo, Margarita Askelson, Hao Tang, Sonia Dolfi, Paolo Antonio Ascierto, Jeffrey S Weber
Adjuvant Nivolumab Versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results From CheckMate 238. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Giselle M Boukhaled, Ramy Gadalla, Heidi J Elsaesser, Diala Abd-Rabbo, Rene Quevedo, S Y Cindy Yang, Mengdi Guo, Ben X Wang, Babak Noamani, Diana Gray, Sally C M Lau, Kirsty Taylor, Kyaw Aung, Anna Spreafico, Aaron R Hansen, Samuel D Saibil, Naoto Hirano, Cynthia J Guidos, Trevor J Pugh, Tracy L McGaha, Pamela S Ohashi, Adrian G Sacher, Marcus O Butler, David G Brooks
Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy. Nature immunology 23 (8) (2022)
Richard D Carvajal, Paul D Nathan, Joseph J Sacco, Marlana Orloff, Leonel F Hernandez-Aya, Jessica Yang, Jason John Luke, Marcus O Butler, Sarah Stanhope, Laura Collins, Cheryl McAlpine, Chris Holland, Shaad E Abdullah, Takami Sato
Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (17) (2022)
Richard D Carvajal, Marcus O Butler, Alexander N Shoushtari, Jessica C Hassel, Alexandra P Ikeguchi, Leonel Hernandez-Aya, Paul Nathan, Omid Hamid, Josep M Piulats, Matthew Rioth, Douglas B Johnson, Jason J Luke, Enrique Espinosa, Serge Leyvraz, Laura Collins, Howard M Goodall, Koustubh Ranade, Chris Holland, Shaad E Abdullah, Joseph J Sacco, Takami Sato
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial. Nature medicine 28 (11) (2022)
Ian Hirsch, Daniel A Goldstein, Ian F Tannock, Marcus O Butler, Duncan C Gilbert
Optimizing the dose and schedule of immune checkpoint inhibitors in cancer to allow global access. Nature medicine 28 (11) (2022)
Kenji Murata, Dalam Ly, Hiroshi Saijo, Yukiko Matsunaga, Kenji Sugata, Fumie Ihara, Daisuke Oryoji, Yota Ohashi, Kayoko Saso, Chung-Hsi Wang, Evey Y F Zheng, Brian D Burt, Marcus O Butler, Naoto Hirano
Modification of the HLA-A*24:02 Peptide Binding Pocket Enhances Cognate Peptide-Binding Capacity and Antigen-Specific T Cell Activation. Journal of immunology (Baltimore, Md. : 1950) 209 (8) (2022)
Jeffrey S Weber, Dirk Schadendorf, Michele Del Vecchio, James M G Larkin, Victoria Atkinson, Michael Schenker, Jacopo Pigozzo, Helen J Gogas, Stéphane Dalle, Nicolas Meyer, Paolo Antonio Ascierto, Shahneen Sandhu, Thomas Eigentler, Ralf Gutzmer, Jessica C Hassel, Caroline Robert, Matteo S Carlino, Anna Maria Di Giacomo, Marcus O Butler, Eva Muñoz Couselo, Michael P Brown, Piotr Lukasz Rutkowski, Andrew M Haydon, Jean-Jacques Grob, Jacob Schachter, Paola Queirolo, Luis de la Cruz Merino, Andre van der Westhuizen, Alexander M Menzies, Sandra Re, Tuba Bas, Veerle de Pril, Julia Braverman, Daniel J Tenney, Hao Tang, Georgina V Long
Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Diana Paola Arteaga Ceballos, Marcus O Butler
Reply to M.Z. Farooq et al. JCO oncology practice 18 (9) (2022)
Diana Paola Arteaga Ceballos, Zaid Saeed-Kamil, Ian King, Tracy L Stockley, Diane Liu, Thiago P Muniz, Samuel D Saibil, David Hogg, Anna Spreafico, Marcus O Butler
Turnaround Times in Melanoma BRAF Testing and the Impact on the Initiation of Systemic Therapy at a Single Tertiary Care Cancer Center. JCO oncology practice 18 (5) (2022)
Antoni Ribas, Alain Patrick Algazi, Paolo Antonio Ascierto, Marcus O Butler, Sunandana Chandra, Michael Gordon, Leonel Hernandez-Aya, Donald Lawrence, Jose Lutzky, Wilson H Miller, Katie M Campbell, Bruno Delafont, Shannon Marshall, Nancy Mueller, Caroline Robert
Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma. Nature communications 12 (1) (2021)
Georgina V Long, Caroline Robert, Marcus O Butler, Felix Couture, Matteo S Carlino, Steven O'Day, Victoria Atkinson, Jonathan S Cebon, Michael P Brown, Stéphane Dalle, Andrew G Hill, Geoffrey T Gibney, Steven McCune, Alexander M Menzies, Cuizhen Niu, Nageatte Ibrahim, Blanca Homet Moreno, Adi Diab
Standard-Dose Pembrolizumab Plus Alternate-Dose Ipilimumab in Advanced Melanoma: KEYNOTE-029 Cohort 1C, a Phase 2 Randomized Study of Two Dosing Schedules. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Deirdre Kelly, April A N Rose, Thiago Pimentel Muniz, David Hogg, Marcus O Butler, Samuel D Saibil, Ian King, Zaid Saeed Kamil, Danny Ghazarian, Kendra Ross, Marco Iafolla, Daniel V Araujo, John Waldron, Normand Laperriere, Hatem Krema, Anna Spreafico
Development of a Metastatic Uveal Melanoma Prognostic Score (MUMPS) for Use in Patients Receiving Immune Checkpoint Inhibitors. Cancers 13 (14) (2021)
Kenji Sugata, Yukiko Matsunaga, Yuki Yamashita, Munehide Nakatsugawa, Tingxi Guo, Levon Halabelian, Yota Ohashi, Kayoko Saso, Muhammed A Rahman, Mark Anczurowski, Chung-Hsi Wang, Kenji Murata, Hiroshi Saijo, Yuki Kagoya, Dalam Ly, Brian D Burt, Marcus O Butler, Tak W Mak, Naoto Hirano
Affinity-matured HLA class II dimers for robust staining of antigen-specific CD4+ T cells. Nature biotechnology 39 (8) (2021)
Sarah Zhou, Daniel Sikorski, Honghao Xu, Andrei Zubarev, May Chergui, François Lagacé, Wilson H Miller, Margaret Redpath, Stephanie Ghazal, Marcus O Butler, Teresa M Petrella, Joël Claveau, Carolyn Nessim, Thomas G Salopek, Robert Gniadecki, Ivan V Litvinov
Defining the Criteria for Reflex Testing for BRAF Mutations in Cutaneous Melanoma Patients. Cancers 13 (9) (2021)
Jedd D Wolchok, Vanna Chiarion Sileni, Rene Gonzalez, Jean-Jacques Grob, Piotr Lukasz Rutkowski, Christopher D Lao, C Lance Cowey, Dirk Schadendorf, John Wagstaff, Reinhard Dummer, Pier Francesco Ferrucci, Michael Smylie, Marcus O Butler, Andrew Hill, Ivan Marquez-Rodas, John B A G Haanen, Massimo Guidoboni, Michele Maio, Patrick Schöffski, Matteo S Carlino, Celeste Lebbè, Grant A McArthur, Paolo Antonio Ascierto, Gregory A Daniels, Georgina V Long, Tuba Bas, Corey Ritchings, James M G Larkin, Frank Stephen Hodi
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
S Y Cindy Yang, Scott C Lien, Ben X Wang, Derek L Clouthier, Youstina Hanna, Iulia Cirlan, Kelsey Zhu, Jeffrey P Bruce, Samah El Ghamrasni, Marco A J Iafolla, Marc Oliva, Aaron R Hansen, Anna Spreafico, Philippe L Bedard, Stephanie Lheureux, Albiruni Razak, Vanessa Speers, Hal K Berman, Alexey Aleshin, Benjamin Haibe-Kains, David G Brooks, Tracy L McGaha, Marcus O Butler, Scott V Bratman, Pamela S Ohashi, Lillian L Siu, Trevor J Pugh
Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity. Nature communications 12 (1) (2021)
Daniel V Araujo, Thiago Pimentel Muniz, Anjie Yang, Sareh Keshavarzi, Hadas Sorotsky, Marcus O Butler, Samuel Saibil, Anna Spreafico, David Hogg
Real World Outcomes and Hepatotoxicity of Infliximab in the Treatment of Steroid-Refractory Immune-Related Adverse Events. Current oncology (Toronto, Ont.) 28 (3) (2021)
Thiago P Muniz, Daniel V Araujo, Kerry J Savage, Tina Cheng, Moumita Saha, Xinni Song, Sabrina Gill, Jose G Monzon, Debjani Grenier, Sofia Genta, Michael J Allen, Diana Paola Arteaga Ceballos, Samuel D Saibil, Marcus O Butler, Anna Spreafico, David Hogg
CANDIED: A Pan-Canadian Cohort of Immune Checkpoint Inhibitor-Induced Insulin-Dependent Diabetes Mellitus. Cancers 14 (1) (2021)
Neesha C Dhani, Hal W Hirte, Lisa Wang, Julia V Burnier, Angela Jain, Marcus O Butler, Stephen Welch, Gini F Fleming, Jean Hurteau, Koji Matsuo, Daniela Matei, Waldo Jimenez, Carolyn Johnston, Mihaela Cristea, Katia Tonkin, Prafull Ghatage, Stephanie Lheureux, Anjali Mehta, Judy Quintos, Qian Tan, Suzanne Kamel-Reid, Olga Ludkovski, Ming-Sound Tsao, John J Wright, Amit M Oza
Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86). Clinical cancer research : an official journal of the American Association for Cancer Research 26 (11) (2020)
Marie Jo Halaby, Kebria Hezaveh, Sara Lamorte, M Teresa Ciudad, Andreas Kloetgen, Bethany L MacLeod, Mengdi Guo, Ankur Chakravarthy, Tiago da Silva Medina, Stefano Ugel, Aristotelis Tsirigos, Vincenzo Bronte, David H Munn, Trevor J Pugh, Daniel D De Carvalho, Marcus O Butler, Pamela S Ohashi, David G Brooks, Tracy L McGaha
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment. Science immunology 4 (42) (2020)
Yuki Kagoya, Tingxi Guo, Brian Yeung, Kayoko Saso, Mark Anczurowski, Chung-Hsi Wang, Kenji Murata, Kenji Sugata, Hiroshi Saijo, Yukiko Matsunaga, Yota Ohashi, Marcus O Butler, Naoto Hirano
Genetic Ablation of HLA Class I, Class II, and the T-cell Receptor Enables Allogeneic T Cells to Be Used for Adoptive T-cell Therapy. Cancer immunology research 8 (7) (2020)
Antoni Ribas, Alain Patrick Algazi, Paolo Antonio Ascierto, Marcus O Butler, Sunandana Chandra, Michael Gordon, Leonel Hernandez-Aya, Donald Lawrence, Jose Lutzky, Wilson H Miller, Katie M Campbell, Bruno Delafont, Shannon Marshall, Nancy Mueller, Caroline Robert
PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma. Nature communications 11 (1) (2020)
Linh T Nguyen, Samuel D Saibil, Valentin Sotov, Michael X Le, Leila Khoja, Danny Ghazarian, Luisa Bonilla, Habeeb Majeed, David Hogg, Anthony M Joshua, Michael Crump, Norman Franke, Anna Spreafico, Aaron Hansen, Ayman Al-Habeeb, Wey Leong, Alexandra Easson, Michael Reedijk, David P Goldstein, David McCready, Kazuhiro Yasufuku, Thomas Waddell, Marcelo Cypel, Andrew Pierre, Bianzheng Zhang, Sarah Boross-Harmer, Jane Cipollone, Megan Nelles, Elizabeth Scheid, Michael Fyrsta, Charlotte S Lo, Jessica Nie, Jennifer Y Yam, Pei Hua Yen, Diana Gray, Vinicius Motta, Alisha R Elford, Stephanie DeLuca, Lisa Wang, Stephanie Effendi, Ragitha Ellenchery, Naoto Hirano, Pamela S Ohashi, Marcus O Butler
Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2. Cancer immunology, immunotherapy : CII 68 (5) (2019)
Jason John Luke, Daniel J Olson, Jacob B Allred, Carrie A Strand, Riyue Bao, Yuanyuan Zha, Timothy Carll, Brian W Labadie, Bruno R Bastos, Marcus O Butler, David Hogg, Pamela N Munster, Gary K Schwartz
Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201). Clinical cancer research : an official journal of the American Association for Cancer Research 26 (4) (2019)
Yuki Kagoya, Shinya Tanaka, Tingxi Guo, Mark Anczurowski, Chung-Hsi Wang, Kayoko Saso, Marcus O Butler, Mark D Minden, Naoto Hirano
A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects. Nature medicine 24 (3) (2018)
Yuki Kagoya, Munehide Nakatsugawa, Kayoko Saso, Tingxi Guo, Mark Anczurowski, Chung-Hsi Wang, Marcus O Butler, Cheryl H Arrowsmith, Naoto Hirano
DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models. Nature communications 9 (1) (2018)
Stephanie Lheureux, Anna Tinker, Blaise Clarke, Prafull Ghatage, Stephen Welch, Johanne I Weberpals, Neesha C Dhani, Marcus O Butler, Katia Tonkin, David Shao Peng Tan, Kelly Brooks, Janelle Ramsahai, Lisa Wang, Nhu-An Pham, Patricia A Shaw, Ming S Tsao, Swati Garg, Tracy L Stockley, Amit M Oza
A Clinical and Molecular Phase II Trial of Oral ENMD-2076 in Ovarian Clear Cell Carcinoma (OCCC): A Study of the Princess Margaret Phase II Consortium. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (24) (2018)
Mark Anczurowski, Yuki Yamashita, Munehide Nakatsugawa, Toshiki Ochi, Yuki Kagoya, Tingxi Guo, Chung-Hsi Wang, Muhammed A Rahman, Kayoko Saso, Marcus O Butler, Naoto Hirano
Mechanisms underlying the lack of endogenous processing and CLIP-mediated binding of the invariant chain by HLA-DP84Gly. Scientific reports 8 (1) (2018)
Tingxi Guo, Ming Yin Koo, Yuki Kagoya, Mark Anczurowski, Chung-Hsi Wang, Kayoko Saso, Marcus O Butler, Naoto Hirano
A Subset of Human Autoreactive CD1c-Restricted T Cells Preferentially Expresses TRBV4-1+ TCRs. Journal of immunology (Baltimore, Md. : 1950) 200 (2) (2017)
Yuki Yamashita, Mark Anczurowski, Munehide Nakatsugawa, Makito Tanaka, Yuki Kagoya, Ankit Sinha, Kenji Chamoto, Toshiki Ochi, Tingxi Guo, Kayoko Saso, Marcus O Butler, Mark D Minden, Thomas Kislinger, Naoto Hirano
HLA-DP84Gly constitutively presents endogenous peptides generated by the class I antigen processing pathway. Nature communications 8 (2017)
Kenji Chamoto, Tingxi Guo, Stephen W Scally, Yuki Kagoya, Mark Anczurowski, Chung-Hsi Wang, Muhammed A Rahman, Kayoko Saso, Marcus O Butler, Priscilla P L Chiu, Jean-Philippe Julien, Naoto Hirano
Key Residues at Third CDR3β Position Impact Structure and Antigen Recognition of Human Invariant NK TCRs. Journal of immunology (Baltimore, Md. : 1950) 198 (3) (2016)